Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia

Movement Disorders

Volumn 23, Issue 6, 2008, Pages 889-892

  von Coelln, Rainer ^a   Raible, Armin ^b   Gasser, Thomas ^a   Asmus, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Botulinum toxin A; Camptocormia; Iliopsoas; Psoas major; Ultrasound guidance

Indexed keywords

BOTULINUM TOXIN A; ANTIPARKINSON AGENT; BOTULINUM TOXIN;

AGED; ARTICLE; BENT SPINE SYNDROME; CAMPTOCORMIA; CASE REPORT; DISEASE ASSOCIATION; DRUG ADMINISTRATION ROUTE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ECHOGRAPHY; FEMALE; FOLLOW UP; GUIDED IMAGERY; HEMATOMA; HUMAN; ILIOPSOAS MUSCLE; INFECTION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; LIMB WEAKNESS; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; PARKINSONISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SELF EVALUATION; SPINE MALFORMATION; TREATMENT RESPONSE; PARKINSON DISEASE; PSOAS MUSCLE; TREATMENT OUTCOME;

AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PSOAS MUSCLES; TREATMENT OUTCOME;

EID: 48649107148     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21967     Document Type: Article

References (15)

1. Djaldetti R, Mosberg-Galili R, Sroka H, Merims D, Melamed E. Camptocormia (bent spine) in patients with Parkinson's disease - characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 1999;14:443-447.
2. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology 2005;65:355-359.
3. Slawek J, Derejko M, Lass P, Dubaniewicz M. Camptocormia or Pisa syndrome in multiple system atrophy. Clin Neurol Neurosurg 2006;108:699-704.
4. Skidmore F, Mikolenko I, Weiss H, Weiner W. Camptocormia in a patient with multiple system atrophy. Mov Disord 2005;20: 1063-1064.
5. Bloch F, Houeto JL, Tezenas du Montcel S, et al. Parkinson's disease with camptocormia. J Neurol Neurosurg Psychiatry 2006; 77:1223-1228.
6. Wunderlich S, Csoti I, Reiners K, et al. Camptocormia in Parkinson's disease mimicked by focal myositis of the paraspinal muscles. Mov Disord 2002;17:598-600.
7. Schabitz WR, Glatz K, Schuhan C, et al. Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord 2003;18: 408-414.
8. Reichel G, Kirchhofer U, Stenner A. [Camptocormia-segmental dystonia. Proposal of a new definition for an old disease]. Nervenarzt 2001;72:281-285.
9. Penning L. Psoas muscle and lumbar spine stability: a concept uniting existing controversies. Critical review and hypothesis. Eur Spine J 2000;9:577-585.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
12. Abdulhadi HM, Kerrigan DC. Camptocormia: a biomechanical analysis. A case report. Am J Phys Med Rehabil 1996;75:310-313.
13. Westhoff B, Seller K, Wild A, Jaeger M, Krauspe R. Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle. Dev Med Child Neurol 2003;45:829-832.
14. Willenborg MJ, Shilt JS, Smith BP, Estrada RL, Castle JA, Koman LA. Technique for itiopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. J Pediatr Orthop 2002;22:165-168.
15. Bogduk N, Pearcy M, Hadfield G. Anatomy and biomechanics of psoas major. Clin Biomech 1992;7:109-119.